CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP AND GC acquired 14,093 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, CHIEF COMMERCIAL OFFICER sold 7,856 shares at $39.65 ($311,490)
- 4 Open-market sale EVP, CHIEF COMMERCIAL OFFICER sold 157,540 shares at an average $39.77 ($6,265,095)
- 4 Open-market sale EVP AND GC sold 26,365 shares at $39.66 ($1,045,517)
- 4 Open-market sale EVP AND GC sold 31,078 shares at $35.15 ($1,092,382)
- 4 Open-market sale EVP AND GC sold 9,800 shares at $30.46 ($298,474)
- 4 Open-market sale EVP AND GC sold 10,000 shares at $30.00 ($300,001)
- 4 Open-market sale EVP AND GC sold 10,200 shares at $30.07 ($306,687)
Page 17 of 35 · 686 filings